Hind Bio Sciences
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Oct 31 (Reuters) - Hindustan Bio Sciences Ltd HISO.BO:
NAMES JAISON GEORGE AS CFO
Source text for Eikon: ID:nBSEbt5VZp
Further company coverage: HISO.BO
(([email protected];))
Oct 31 (Reuters) - Hindustan Bio Sciences Ltd HISO.BO:
NAMES JAISON GEORGE AS CFO
Source text for Eikon: ID:nBSEbt5VZp
Further company coverage: HISO.BO
(([email protected];))
Sept 4 (Reuters) - Hindustan Bio Sciences Ltd HISO.BO:
GALI SESHAVATARAM RESIGNS AS CFO
Source text for Eikon: ID:nBSE1YnPdl
Further company coverage: HISO.BO
(([email protected];))
Sept 4 (Reuters) - Hindustan Bio Sciences Ltd HISO.BO:
GALI SESHAVATARAM RESIGNS AS CFO
Source text for Eikon: ID:nBSE1YnPdl
Further company coverage: HISO.BO
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Hind Bio Sciences do?
Hindustan Bio Sciences Limited is a public limited company established in 1991, specializing in the manufacturing and sale of pharmaceutical products.
Who are the competitors of Hind Bio Sciences?
Hind Bio Sciences major competitors are Decipher Labs, Ganga Pharma, Senbo Industries, Secunderabad Health., Adline Chem Lab, Hemo Organic, Zyden Gentec. Market Cap of Hind Bio Sciences is ₹8 Crs. While the median market cap of its peers are ₹8 Crs.
Is Hind Bio Sciences financially stable compared to its competitors?
Hind Bio Sciences seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Hind Bio Sciences pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Hind Bio Sciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Hind Bio Sciences allocated its funds?
Companies resources are allocated to majorly unproductive assets like Short Term Loans & Advances
How strong is Hind Bio Sciences balance sheet?
Hind Bio Sciences balance sheet is weak and might have solvency issues
Is the profitablity of Hind Bio Sciences improving?
Yes, profit is increasing. The profit of Hind Bio Sciences is ₹0.1 Crs for Mar 2025, ₹0.06 Crs for Mar 2024 and -₹0.04 Crs for Mar 2023
Is the debt of Hind Bio Sciences increasing or decreasing?
The net debt of Hind Bio Sciences is decreasing. Latest net debt of Hind Bio Sciences is ₹2.22 Crs as of Mar-26. This is less than Mar-25 when it was ₹2.48 Crs.
Is Hind Bio Sciences stock expensive?
Hind Bio Sciences is not expensive. Latest PE of Hind Bio Sciences is 0, while 3 year average PE is 94.73. Also latest EV/EBITDA of Hind Bio Sciences is 0.0 while 3yr average is 308.
Has the share price of Hind Bio Sciences grown faster than its competition?
Hind Bio Sciences has given better returns compared to its competitors. Hind Bio Sciences has grown at ~34.1% over the last 9yrs while peers have grown at a median rate of 7.02%
Is the promoter bullish about Hind Bio Sciences?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Hind Bio Sciences is 12.19% and last quarter promoter holding is 12.19%.
Are mutual funds buying/selling Hind Bio Sciences?
There is Insufficient data to gauge this.